Pharmed Pharmaceutical Pty Ltd has sold a 65% stake to Imperial Holdings Limited
Lenmed Health Pty Ltd has sold a 65% stake in Pharmed Pharmaceutical Pty Ltd to Imperial Holdings Limited for US$10 million.
Pharmed Pharmaceutical Pty Ltd distributes pharmaceutical and other healthcare products in South Africa. The company was founded in 1985 in Overport, Durban by a group of healthcare professionals from previously disadvantaged communities.
Imperial Holdings Limited is a JSE-listed, South African-based international group of companies active in three major areas of mobility: consumer and industrial logistics, vehicle import, distribution, dealerships, retail, rental and aftermarket parts and vehicle-related financial services. The company employs around 52,000 people who generate revenues in excess of US$7.5 billion per year in Africa, Europe, South America, Australia and the USA through five major divisions which operate under separate management structures to enable decentralized entrepreneurial creativity within the group’s clearly defined strategic, capital, budgetary and governance principles.
Lenmed Health is an established black owned hospital group in South Africa, operating multi-specialty hospital facilities in South Africa, Mozambique and Botswana and managing in excess of 1,300 beds.
Oaklins' team in South Africa advised the seller in this transaction.
Talk to the deal team
Related deals
EuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreMEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn more